Conservative treated | AVR | AVR + AA surgery | |
N | 24 | 63 | 13 |
AA-diameter (cm) | 3.99±0.55 | 3.91±0.58 | 5.02±0.55* |
BAV phenotype, n (%) | |||
RN | 5 (21) | 8 (13) | 1 (8) |
RL | 16 (67) | 46 (73) | 10 (77) |
LA | 2 (8) | 6 (9) | 2 (15) |
AP | 1 (4) | 3 (5) | 0 (0) |
Aortic valve area (cm2) | 2.36±1.51 | 1.71±1.40 | 2.25±1.59 |
1.55 (0.70–6.50) | 0.95 (0.60–6.24) | 1.50 (0.8–5.58) | |
Aortic regurgitation >30% RF, n (%) | 7 (29) | 18 (29) | 4 (31) |
↵* p<0.05 AVR+AA surgery vs. AVR and vs. conservative treated group.
AA, ascending aorta; AVR, aortic valve replacement; BAV, bicuspid aortic valve; BAV-RL, fusion of the right and left-coronary cusps; BAV-RN, fusion of the right and non-coronary cusps; BAV-LA, lateral orientation; BAV-AP, anterior-posterior orientation; RF, regurgitation fraction.